Le Lézard
Classified in: Health, Business
Subjects: CCA, FVT, MAT

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET


TORONTO and GLIL YAM, Israel, Nov. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens.

IM Cannabis Logo

The Company will host a zoom web conference on the same day at 9:00 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com within 24 hours after the call.

Link for the zoom call: https://us02web.zoom.us/webinar/register/WN_4KdMNcEESymEAfNDysW-Jg

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
[email protected]

SOURCE IM Cannabis Corp.


These press releases may also interest you

at 11:37
A recent national survey by Action for Healthy Kids (AFHK) reports that among parents' top concerns for their children's health is their mental health, but less than 20% of parents indicated awareness of all the mental health resources and services...

at 11:33
ANALYGENCE, a leader in mission-focused cyber solutions and intelligence services supporting the military, intelligence, and federal civilian communities, is excited to announce a new task order award supporting the National Institute of Standards...

at 11:13
La Roche-Posay, the worldwide expert in advanced UV protection, is thrilled to announce its partnership as the official sunscreen partner of the Mubadala Citi DC Open. Research suggests sunburns are highly tied to physical activity and a large...

at 11:08
The ProxsysRx specialty pharmacy team, led by VP Heather Brooks and Compliance & Accreditation Manager Lauren Robinson, has earned accreditation status from URAC ? the medical profession's gold standard for third-party validation of high-quality...

at 11:07
Today, Vote for Abortion, a people-powered reproductive rights movement inspiring people to use their voices this November, announced its second activation, which will take place across Philadelphia on July 27. Celebrities, influencers, activists,...

at 11:00
OCuSOFT Inc., a privately-held eye and skin care company with an established reputation for innovation in eyelid hygiene is pleased to announce the availability of NEW OCuSOFT® Retaine® Allergy original prescription strength antihistamine tears for...



News published on and distributed by: